eXoZymes, Inc. (EXOZ) investor relations documents from the company's IR site: 2 presentations; latest deck 2026-05-06. Read in-app with summaries. First-party data.
Download slidedeck: eXoZymes is a cell-free biomanufacturing company using AI-engineered enzymes to produce rare, high-purity molecules for nutraceutical and pharmaceutical markets.
| Published | Type | Document |
|---|---|---|
| 2026-05-06 | Presentation | Download slidedeck |
| 2026-04-01 | Presentation | Download slidedeck |
EXOZ overview · EXOZ earnings · EXOZ financials · EXOZ KPIs · EXOZ ownership · EXOZ peers · EXOZ filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.